The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle
Open accessAbstract
Recent studies have demonstrated that fatty acids induce insulin resistance in skeletal muscle by blocking insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase (PI3-kinase). To examine the mechanism by which fatty acids mediate this effect, rats were infused with either a lipid emulsion (consisting mostly of 18:2 fatty acids) or glycerol. Intracellular C18:2 CoA increased in a time-dependent fashion, reaching an approximately 6-fold elevation by 5 h, whereas there was no change in the concentration of any other fatty acyl-CoAs. Diacylglycerol (DAG) also increased transiently after 3-4 h of lipid infusion. In contrast there was no increase in intracellular ceramide or triglyceride concentrations during the lipid infusion. Increases in intracellular C18:2 CoA and DAG concentration were associated with protein kinase C (PKC)-theta activation and a reduction in both insulin-stimulated IRS-1 tyrosine phosphorylation and IRS-1 associated PI3-kinase activity, which were associated with an increase in IRS-1 Ser(307) phosphorylation. These data support the hypothesis that an increase in plasma fatty acid concentration results in an increase in intracellular fatty acyl-CoA and DAG concentrations, which results in activation of PKC-theta leading to increased IRS-1 Ser(307) phosphorylation. This in turn leads to decreased IRS-1 tyrosine phosphorylation and decreased activation of IRS-1-associated PI3-kinase activity resulting in decreased insulin-stimulated glucose transport activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Lipid accumulation in skeletal muscle (7) or metabolic overload in mitochondria (8) have also been shown to occur with IR”
From TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle (2019) · cites this paper as [7]
In the citing paper
“Both acute (4 hours) and chronic (4 days) physiologic elevation of plasma FFA concentration in insulin sensitive individuals impairs insulin signaling and causes insulin resistance in skeletal muscle [28, 62–68].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [64]
In the citing paper
“It is well established that chronically elevated plasma FFA levels cause insulin resistance in skeletal muscle [1, 12, 14, 62–65].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [64]
In the citing paper
“Rodent and human studies have suggested increased serine phosphorylation of IRS-1 in insulin resistant states [111, 171–173].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [173]
In the citing paper
“GLUT4, the insulin regulatable transporter, is found in skeletal muscle, has a Km of approximately 5 mmol/L, which is close to that of the plasma glucose concentration, and is associated with HK-II [173, 174].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [173]
In the citing paper
“While increased levels of fatty acyl-CoA in general are associated with IR and in C18:2-CoA accumulation is a potential indicator of IR [115,117].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [117]
In the citing paper
“In particular, an overabundance of SFA (e.g., Palmitate) can induce IR through the accumulation of lipid derivatives including DAGs, ceramides and long chain acyl-CoAs in the cytosol, which in turn can interfere with IRS1-PKB signalling [113,114,115,116,117,118].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [117]
In the citing paper
“In contrast, decreasing fatty acid flux in humans via pharmacological inhibition of lipolysis (49) or by discontinuing a lipid-plus-heparin infusion in rats (58) decreases IMTG concentration and/or the accumulation of fatty acid intermediates.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [58]
In the citing paper
“Accordingly, increasing fatty acid flux via a lipid-plus-heparin infusion in humans (23,46) or rodents (58) results in a corresponding increase in the concentration of IMTG and/or fatty acid intermediates.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [58]
In the citing paper
“Adipose tissue in obese people is insulin resistant, which raises nonesterified fatty acid levels, worsening insulin resistance in muscle 29,33 and altering hepatic metabolism 31 ;”
From Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (2005) · cites this paper as [33]
In the citing paper
“This disconnection between intramyocellular triglyceride and peripheral insulin action confirms that intra myocellular triglyceride is only a crude marker for the active metabolite (putatively diacylglycerol) that causes fat-induced insulin resistance.38”
From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [38]
In the citing paper
“Increased tissue lipid load, as with obesity, and/or sustained inactivity, may lead to the accumulation of fatty acyl coenzyme A (CoA), diacylglycerols, ceramides, products of incomplete oxidation, and ROS, all of which have been linked experimentally to reduced insulin signaling and action (96 -102).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Self-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Self-citationGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264
Self-citationSkeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
Skeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Storlien, L. H., Jenkins, A. B., Chisholm, D. J., Pascoe, W. S., Khouri, S., & Kraegen, E. W. (1991) · Diabetes · doi:10.2337/diab.40.2.280 · Cited by 967
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Laybutt, 1999, Am. J. Physiol., 277, E1070
Cited by
Sorted by citations
Items 701–800 of 1,002
Leptin, skeletal muscle lipids, and lipid-induced insulin resistance
Dubé, J. J., Bhatt, B. A., Dedousis, N., Bonen, A., & O'Doherty, R. M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00133.2007 · Cited by 47
Macrae, K., Stretton, C., Lipina, C., Blachnio-Zabielska, A., Baranowski, M., Gorski, J., Marley, A., & Hundal, H. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m036996 · Cited by 46
Verdú, E., Homs, J., & Boadas‐Vaello, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182413333 · Cited by 57
Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 53
Błachnio-Zabielska, A. U., Koutsari, C., & Jensen, M. D. (2011) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.5110 · Cited by 46
Boden, G. H., & Merali, S. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-385116-1.00004-2 · Cited by 46
Hippocampal calcium dysregulation at the nexus of diabetes and brain aging
Thibault, O., Anderson, K. L., DeMoll, C., Brewer, L. D., Landfield, P. W., & Porter, N. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.024 · Cited by 46
PKCθ is a key player in the development of insulin resistance
Haasch, D. L., Berg, C. E., Clampit, J. E., Pederson, T. M., Frost, L., Kroeger, P., & Rondinone, C. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.177 · Cited by 46
Aging per se Increases the Susceptibility to Free Fatty Acid-Induced Insulin Resistance
Einstein, F. H., Huffman, D. M., Fishman, S., Jerschow, E., Heo, H. J., Atzmon, G., Schechter, C. B., Barzilai, N., & Muzumdar, R. H. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq078 · Cited by 46
RNAi screening for kinases and phosphatases identifies FoxO regulators
Mattila, J., Kallijärvi, J., & Puig, Ó. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803022105 · Cited by 47
Gong, L., Zou, Z., Huang, L., Guo, S., & Xing, D. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109491 · Cited by 48
The cat as a model for human nutrition and disease
Hoenig, M. E. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241668.30761.69 · Cited by 45
Park, H., Hasegawa, G., Shima, T., Fukui, M., Nakamura, N., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.012 · Cited by 46
Molero, J. C., Waring, S. G., Cooper, A., Turner, N. A., Laybutt, D. R., Cooney, G. J., & James, D. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0312 · Cited by 45
Self-citationAdding fat calories to meals after exercise does not alter glucose tolerance
Fox, A. K., Kaufman, A. E., & Horowitz, J. F. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01398.2003 · Cited by 46
He, J., Quintana, M. T., Sullivan, J., Parry, T. L., Grevengoed, T. J., Schisler, J. C., Hill, J. A., Yates, C. C., Mapanga, R. F., Essop, M. F., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0252-x · Cited by 44
Raised Serum Adenosine Deaminase Level in Nonobese Type 2 Diabetes Mellitus
Khemka, V. K., Bagchi, D., Ghosh, A., Sen, O., Bir, A., Chakrabarti, S., & Banerjee, A. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/404320 · Cited by 45
Dunlop, K., Cedrone, M., Staples, J. F., & Regnault, T. R. H. (2015) · Nutrients · doi:10.3390/nu7021202 · Cited by 45
Song, H., Wohltmann, M., Bao, S. S., Ladenson, J. H., Semenkovich, C. F., & TURK, J. W. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00780.2009 · Cited by 49
Persistent Organic Pollutant-Mediated Insulin Resistance
Kim, Y. A., Park, J. B., Woo, M. S., Lee, S. Y., Kim, H. Y., & Yoo, Y. H. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16030448 · Cited by 50
Jiang, G., Dallas-Yang, Q., Biswas, S., Li, Z., & Zhang, B. B. (2004) · Biochemical Journal · doi:10.1042/bj20031207 · Cited by 45
Roorda, B. D., Hesselink, M. K. C., Schaart, G., Moonen‐Kornips, E., Martínez‐Martínez, P., Losen, M. H., Baets, M. H. D., Mensink, R. P., & Schrauwen, P. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400416-jlr200 · Cited by 45
Liver and Muscle in Morbid Obesity: The Interplay of Fatty Liver and Insulin Resistance
Machado, M. V., Ferreira, D. M. S., Castro, R. E., Silvestre, A. R., Evangelista, T., Coutinho, J., Carepa, F., Costa, A., Rodrigues, C. M. P., & Cortez‐Pinto, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031738 · Cited by 49
Prasannarong, M., Vichaiwong, K., & Saengsirisuwan, V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.018 · Cited by 44
Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21
Camporez, J. P., Asrih, M., Zhang, D., Kahn, M., Samuel, V. T., Jurczak, M. J., & Jornayvaz, F. R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0136 · Cited by 44
Self-citationMacrophage Rewiring by Nutrient Associated PI3K Dependent Pathways
Sharif, O., Brunner, J. S., Vogel, A., & Schabbauer, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02002 · Cited by 47
Egawa, T., Tsuda, S., Ma, X., Hamada, T., & Hayashi, T. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00249.2011 · Cited by 46
Insulin and Oleate Promote Translocation of Inosine‐5′ Monophosphate Dehydrogenase to Lipid Bodies
Whitehead, J. P., Simpson, F., Hill, M. M. C., Thomas, E. C., Connolly, L., Collart, F., Simpson, R. J., & James, D. E. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00217.x · Cited by 44
Abulizi, A., Perry, R. J., Camporez, J. P. G., Jurczak, M. J., Petersen, K. F., Aspichueta, P., & Shulman, G. I. (2017) · The FASEB Journal · doi:10.1096/fj.201700001r · Cited by 41
Self-citationCeramide: a contributor to insulin resistance or an innocent bystander?
Boden, G. (2008) · Diabetologia · doi:10.1007/s00125-008-1015-y · Cited by 43
Ghowsi, M., Khazali, H., & Sisakhtnezhad, S. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.24801.6167 · Cited by 43
Mechanisms of Hemorrhage-Induced Hepatic Insulin Resistance: Role of Tumor Necrosis Factor-α
Ma, Y., Tóth, B. I., Keeton, A. B., Holland, L. T., Chaudry, I. H., & Messina, J. L. (2004) · Endocrinology · doi:10.1210/en.2004-0524 · Cited by 42
RetractedWaraich, R. S., Weigert, C., Kalbacher, H., Hennige, A. M., Lutz, S. Z., Häring, H., Schleicher, E. D., Voelter, W., & Lehmann, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708588200 · Cited by 43
ter Veld, F., Primaßin, S., Hoffmann, L., Mayatepek, E., & Spiekerkoetter, U. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800221-jlr200 · Cited by 43
Souza, A. T. D., Cornwell, P. D., Dai, X., Caguyong, M. J., & Ulrich, R. G. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl019 · Cited by 43
Beck Jørgensen, S., O’Neill, H. M., Hewitt, K., Kemp, B. E., & Steinberg, G. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1483-8 · Cited by 42
Jiang, C., Yao, N., Wang, Q., Zhang, J., Sun, Y., Xiao, N., Liu, K., Huang, F., Fang, S., Shang, X., et al. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.02.003 · Cited by 42
Peroxisome proliferator-activated receptor translational research and clinical experience
Cheatham, W. W. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28449d · Cited by 42
Nochioka, K., Shiba, N., Kohno, H., Miura, M., & Shimokawa, H. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.06.413 · Cited by 42
Mcl-1 Degradation during Hepatocyte Lipoapoptosis
Masuoka, H. C., Mott, J. L., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kaufmann, S. H., & Gores, G. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039545 · Cited by 42
Fowler, M. A., Champagne, C. D., Houser, D. S., & Crocker, D. E. (2008) · Journal of Experimental Biology · doi:10.1242/jeb.018176 · Cited by 42
IL-6: A Potential Role in Cardiac Metabolic Homeostasis
Xu, Y., Zhang, Y., & Ye, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092474 · Cited by 42
Dissociation of Muscle Insulin Resistance from Alterations in Mitochondrial Substrate Preference
Song, J. D., Alves, T. C., Befroy, D. E., Perry, R. J., Mason, G. F., Zhang, X., Munk, A., Zhang, Y., Zhang, D., Cline, G. W., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.09.008 · Cited by 40
Self-citationHigh-fat load: mechanism(s) of insulin resistance in skeletal muscle
Lark, D. S., Fisher‐Wellman, K. H., & Neufer, P. D. (2012) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2012.20 · Cited by 41
Mário, É. G., Santos, S. H. S., Ferreira, A. V. M., Bäder, M., Santos, R. A. S., & Botion, L. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.014 · Cited by 41
Epicardial Adipose Tissue in Cardiovascular Disease
Berg, G. A., Miksztowicz, V., Morales, C., & Barchuk, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_9 · Cited by 41
Molecular Mechanisms of Insulin Resistance Development
Va, T., & Vorotnikov, A. V. (2014) · Diabetes Mellitus · doi:10.14341/dm2014229-40 · Cited by 48
Determining the relationship between dietary carbohydrate intake and insulin resistance
McClenaghan, N. H. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005109 · Cited by 42
Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment
Bikman, B. T., Zheng, D., Reed, M. A., Hickner, R. C., Houmard, J. A., & Dohm, G. L. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00190.2009 · Cited by 42
The Role of Skeletal Muscle Sphingolipids in the Development of Insulin Resistance
Strączkowski, M., & Kowalska, I. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.13 · Cited by 43
Role of lipid-derived mediators in skeletal muscle insulin resistance
Taube, A., Eckardt, K., & Eckel, J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00241.2009 · Cited by 40
Wensley, I., Salaveria, K., Bulmer, A. C., Donner, D. G., & Toit, E. F. D. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2013.074948 · Cited by 40
PEDF-induced alteration of metabolism leading to insulin resistance
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.006 · Cited by 41
van den Broek, N. M. A., Čiapaitė, J., Nicolay, K., & Prompers, J. J. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00200.2010 · Cited by 41
Darimont, C., Turini, M. E., Epitaux, M., Zbinden, I., Richelle, M., Montell, E., Ferrer-Martı́nez, A., & Macé, K. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-4 · Cited by 41
Kim, T. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000401 · Cited by 42
Perry, R. J., Lyu, K., Rabin-Court, A., Dong, J., Li, X., Yang, Y., 青华, Wang, A., Yang, X., & Shulman, G. I. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134699 · Cited by 41
Self-citationSánchez‐Alegría, K., Bastián‐Eugenio, C. E., Vaca, L. A., & Arias, C. (2021) · The FASEB Journal · doi:10.1096/fj.202100243r · Cited by 40
Tinkov, A. A., Синицкий, А. И., Popova, E. V., Немерешина, О. Н., Gatiatulina, E. R., Геннадиевна, С. М., Skalny, A. V., & Nikonorov, A. А. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.06.005 · Cited by 40
Høeg, L. D., Sjøberg, K. A., Lundsgaard, A., Jordy, A. B., Hiscock, N. J., Wojtaszewski, J. F. P., Richter, E. A., & Kiens, B. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01046.2012 · Cited by 41
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome
Alcover, S., Ramos-Regalado, L., Girón, G., Muñoz‐García, N., & Vilahur, G. (2025) · Antioxidants · doi:10.3390/antiox14040434 · Cited by 50
Wang, C., Liu, M., Riojas, R. A., Xin, X., Gao, Z., Zeng, R., Wu, J., Dong, L., & Liu, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806336200 · Cited by 39
Imierska, M., Kurianiuk, A., & Błachnio-Zabielska, A. U. (2020) · Biomolecules · doi:10.3390/biom10121665 · Cited by 44
Chueire, V. B., & Muscelli, E. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000313 · Cited by 41
Lim, M. J., Choi, K. J., Ding, Y., Kim, J. H., Kim, B. S., Kim, Y. H., Lee, J., Choe, W., Kang, I., Ha, J., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0114 · Cited by 40
Self-citationAshry, F. E. Z. Z. E., Mahmoud, M. F., Maraghy, N. N. E., & Ahmed, A. F. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.12.020 · Cited by 39
Li, L., Thompson, L. H., Zhao, L., & Messina, J. L. (2008) · Endocrinology · doi:10.1210/en.2008-0742 · Cited by 38
Haluzı́k, M., Gavrilova, O., & LeRoith, D. (2003) · Endocrinology · doi:10.1210/en.2003-1015 · Cited by 39
Gorgey, A. S., Graham, Z., Bauman, W. A., Cardozo, C. P., & Gater, D. R. (2016) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2016.1229397 · Cited by 38
Myocardial Energy Stress, Autophagy Induction, and Cardiomyocyte Functional Responses
Daniels, L. J., Varma, U., Annandale, M., Chan, E., Mellor, K. M., & Delbridge, L. M. D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7650 · Cited by 38
Lyu, K., Zhang, D., Song, J. D., Li, X., Perry, R. J., Samuel, V. T., & Shulman, G. I. (2021) · JCI Insight · doi:10.1172/jci.insight.139946 · Cited by 38
Self-citationPosttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
Pérez-García, A., Torrecilla-Parra, M., Frutos, M. F.-D., Martín-Martín, Y., Pardo, V., & Ramírez, C. M. (2022) · Biomolecules · doi:10.3390/biom12020208 · Cited by 45
Yang, L., Qian, Z., Ji, H., Yang, R., Wang, Y., Liang, X., Sheng, L., Zhao, B., & Zhang, X. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.061 · Cited by 38
Self-citationLang, C. H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00065.2006 · Cited by 39
Dokken, B. B., & Henriksen, E. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00628.2005 · Cited by 39
Handy, R. M., & Holloway, G. P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1151389 · Cited by 38
“Within skeletal muscle, DAGs have been demonstrated to activate PKC-θ and PKC-ε in both human and rodent models (Itani et al., 2002; Yu et al., 2002; Szendroedi et al., 2014; Lee et al., 2017).”
BackgroundThe Novel PKCθfrom Benchtop to Clinic
Hage‐Sleiman, R., Hamze, A. B., Reslan, L., Kobeissy, H., & Dbaibo, G. S. (2015) · Journal of Immunology Research · doi:10.1155/2015/348798 · Cited by 38
Hwang, S., Yang, J., Jeong, Y., Kim, Y. D., Li, X., Lü, Y., Chang, Y., Son, K. H., & Chang, H. W. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.066 · Cited by 38
Mechanisms involved in cholesterol-induced neuronal insulin resistance
Taghibiglou, C., Bradley, C. A., Gaertner, T. R., Li, Y., Wang, Y., & Wang, Y. T. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.05.013 · Cited by 37
Self-citationHoeks, J., Mensink, M., Hesselink, M. K. C., Ekroos, K., & Schrauwen, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1884 · Cited by 37
Orphan nuclear receptors: therapeutic opportunities in skeletal muscle
Smith, A. G., & Muscat, G. E. O. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00476.2005 · Cited by 37
Watt, M. J., van Denderen, B. J. W., Castelli, L. A., Bruce, C. R., Hoy, A. J., Kraegen, E. W., Macaulay, L. S., & Kemp, B. E. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0485 · Cited by 37
Self-citationRetractedPotential regulatory role of the farnesoid X receptor in the metabolic syndrome
Durán-Sandoval, D., Cariou, B., Fruchart, J., & Staels, B. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.018 · Cited by 37
Miller, M. R., Pereira, R. I., Langefeld, C. D., Lorenzo, C., Rotter, J. I., Chen, Y. I., Bergman, R. N., Wagenknecht, L. E., Norris, J. M., & Fingerlin, T. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1318 · Cited by 36
Self-citationAhn, H. Y., Kim, M., Seo, C. R., Yoo, H. J., Lee, S., & Lee, J. H. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0052-y · Cited by 38
Błachnio-Zabielska, A. U., Hady, H. R., Markowski, A. R., Kurianiuk, A., Karwowska, A., Górski, J., & Zabielski, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123995 · Cited by 36
Bilet, L., Phielix, E., van de Weijer, T., Gemmink, A., Bosma, M., Moonen‐Kornips, E., Jörgensen, J. A., Schaart, G., Zhang, D., Meijer, K., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05128-1 · Cited by 37
Self-citationØstergård, T., Jessen, N., Schmitz, O., & Mandarino, L. J. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-031 · Cited by 36
Sugden, M. C. (2003) · Obesity Research · doi:10.1038/oby.2003.26 · Cited by 36
Adipokines--targeting a root cause of cardiometabolic risk
Bakhai, A. (2008) · QJM · doi:10.1093/qjmed/hcn066 · Cited by 37
Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System
D’Oria, R., Genchi, V. A., Caccioppoli, C., CALDERONI, I., Marrano, N., Biondi, G., Borrelli, A., Gioia, L. D., Giorgino, F., & Laviola, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214296 · Cited by 38
Liang, Y., Kaushal, D., & Wilson, R. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147943 · Cited by 40
Parry, S. A., Smith, J. R., Corbett, T. R. B., Woods, R. M., & Hulston, C. J. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114516004475 · Cited by 35
Role of Diacylglycerol Kinases in Glucose and Energy Homeostasis
Massart, J., & Zierath, J. R. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.06.003 · Cited by 35
TNF-α knockdown alleviates palmitate-induced insulin resistance in C2C12 skeletal muscle cells
Haghani, K., Pashaei, S., Vakili, S., Taheripak, G., & Bakhtiyari, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.137 · Cited by 36
Role of stearoyl-CoA desaturase in human metabolic disease
Sampath, H., & Ntambi, J. M. (2008) · Future Lipidology · doi:10.2217/17460875.3.2.163 · Cited by 35
Mechanism of Obesity-Related Lipotoxicity and Clinical Perspective
Engin, A. B. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_5 · Cited by 37
Anastasiou, C. A., Kavouras, S. A., Lentzas, Y., Gova, A., Sidossis, L. S., & Melidonis, A. (2009) · Metabolism · doi:10.1016/j.metabol.2009.05.019 · Cited by 34
The macrophage at the intersection of immunity and metabolism in obesity
Samaan, M. C. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-29 · Cited by 34
Defining lipid mediators of insulin resistance: controversies and challenges
Metcalfe, L. K., Smith, G. C., & Turner, N. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0023 · Cited by 35
Metadata
- Authors
- Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., Atcheson, B., White, M. F., Kraegen, E. W., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- National Institutes of Health (US)
- Garvan Institute of Medical Research (AU)
- Joslin Diabetes Center (US)
- Corresponding author
- Shulman, Gerald I.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 52
- Pages
- 50230-50236
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2130850001
- Cited by
- 1,561
- References
- 21
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 36 · 2023: 27 · 2022: 26 · 2021: 47 · 2020: 55 · 2019: 52 · 2018: 56 · 2017: 71 · 2016: 65 · 2015: 65 · 2014: 77 · 2013: 97 · 2012: 101
- FWCI
- 22.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P30 DK, DK-45735)
- Medical Research Council
- National Health and Medical Research Council
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01-DK40936, R01DK040936, P30DK045735)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- fatty acids, insulin resistance, skeletal muscle, IRS-1, phosphatidylinositol 3-kinase, protein kinase C theta, diacylglycerol, fatty acyl-CoA, IRS-1 serine phosphorylation, IRS-1 tyrosine phosphorylation, glucose transport, lipid emulsions
- MeSH terms
- Animals, Diglycerides, Fat Emulsions, Intravenous, Fatty Acids, Nonesterified, Insulin, Kinetics, Male, Phosphoproteins, Phosphorylation, Rats, Wistar, Muscle, Skeletal, Phosphotyrosine, Phosphatidylinositol 3-Kinases, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
